Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma – BioSpace *  Clark Athletics Report: This week in Penguins athletics, Feb. 18 *  Airdrie massage therapist found guilty of sexual assault – *  Brazil gives big tobacco companies 30 days notice in smoking lawsuit *  Sir Elton John plans to complete tour – Herald-Mail Media *